The ThruPLEX Plasma-Seq Kit has been designed for use with cell-free DNA isolated from plasma. The following protocol outlines the method used by the scientific staff at Takara Bio to collect blood and prepare high-quality plasma. The prepared plasma samples are then used for the isolation of the cell-free DNA.
User-generated protocol
Plasma preparation for the ThruPLEX Plasma-Seq workflow
Introduction
Materials required
- Gloves, disinfectant, swabs, and tourniquets
- BD Vacutainer Venous Blood Collection Tubes with K2 EDTA, 10 mL (Becton Dickinson, Cat. No. 366643)
- 15-ml and 50-ml centrifuge tubes
- Centrifuge, calibrated, capable of 1,500g with brake off switch
- –70°C or colder freezer (or dry ice storage container)
Protocol
Blood draw
- Prelabel and use Vacutainer tubes with K2 EDTA to draw blood from subjects.
- Check that the collection tubes are filled appropriately as defined in the Vacutainer product insert. Blood from tubes with reduced volume should not be processed. For specific blood draw instructions, refer to the Vacutainer package insert.
- Immediately after filling each tube, invert the tube 10 times gently. (Inversion can be performed while subsequent tubes are being filled.)
- Allow the blood tubes to stand at room temperature for approximately 30 minutes prior to centrifugation. If the centrifuge used is capable of refrigeration, then this time may be shortened.
NOTE: Specimens must be processed and frozen within four hours of blood draw.
First centrifugation
- If the centrifuge has an external brake, ensure that the brake switch is off. Set temperature to 4°C, if centrifuge allows.
- Centrifuge blood in the collection tubes for 12 minutes at 1,500g.
- Remove the tubes from the centrifuge. If any of the Vacutainer tubes demonstrate gross hemolysis (bright red plasma), discard them. Continue processing of the other, non-hemolyzed tubes.
- After centrifugation, the buffy coat (white cellular layer) is visible as a very small, whitish band above the red blood cells (Figure 1). Be careful not to disturb the buffy coat in the Vacutainer tubes.
- Using a disposable bulb pipette, transfer plasma from each collection tube to a 15-ml centrifuge tube.
- To minimize risk of aspirating cells from the buffy coat, hold the Vacutainer tube upright and tilt the pipette to touch the Vacutainer tube in two positions (see red circles in Figure 1) and slowly move the pipette down while aspirating.
- Always place the pipette at the top of the plasma layer and stop aspirating at about 5 mm or >1/4" above the buffy coat in order to avoid contaminating the plasma with cells. If cells are aspirated, do not add existing plasma sample; dispose of the pipette and Vacutainer tube.
NOTE: Centrifugation separates plasma from white and red blood cells as shown in Figure 1. The most critical parts of the sample preparation process are to leave sufficient residual volume in the tubes after the centrifugation and not to disturb the buffy coat when pipetting. Reducing the residual volume will reduce plasma quality.
Second centrifugation
- Centrifuge plasma in the 15-ml centrifuge tubes for 12 minutes at 1,500g.
- Using a clean, disposable bulb pipette, transfer plasma from each centrifuge tube to a 15-ml or 50-ml pooling tube.
- Leave a residual amount of plasma (>0.5 ml; 12 mm or 1/2" in height) in the bottom of the centrifuge tube to avoid contamination with the pelleted cells as shown in Figure 2.
- Gently swirl to mix plasma in the pooling tube and record the total plasma volume.
- Freeze plasma in the pooling tubes upright in a –70°C or –80°C freezer, or bury in dry ice (within four hours of blood draw). If necessary, temporary storage at –20°C overnight is acceptable.
- Store samples in a –70°C or –80°C freezer (or in a dry ice storage container) until use.
- Discard all used blood collection and processing tubes and pipettes as biohazardous waste.
NOTE: Processing blood as directed should result in ~4 ml of plasma per Vacutainer tube.
Related Products
User-generated protocols
User-generated protocols are based on internal proof-of-concept experiments, customer collaborations, and published literature. In some cases, relevant results are discussed in our research news BioView blog articles. While we expect these protocols to be successful in your hands, they may not be fully reviewed or optimized. We encourage you to contact us or refer to the published literature for more information about these user-generated and -reported protocols.
If you are looking for a product-specific, fully optimized User Manual or Protocol-At-A-Glance, please visit the product's product page, open the item's product details row in the price table, and click Documents. More detailed instructions for locating documents are available on our website FAQs page.
Questions? Protocols of your own that you would like to share?
Contact technical support Give feedbackcfDNA isolation from up to 10 ml of plasma
NucleoSnap cfDNA & NucleoMag cfDNA
- Consistent recovery of fragmented cfDNA ≥50 bp from plasma obtained in EDTA or Cell-Free DNA BCT tubes
- Efficient removal of PCR inhibitors regardless of input volume
- Convenient manual or automated processing using snap-off columns or magnetic beads
- Suitable for downstream applications such as qPCR and NGS
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.